Recombinant poxvirus based vaccine against SARS-cov-2 virus

MYPI2026004802A0Undetermined Publication Date: 2021-08-26THE GOVERNORS OF THE UNIV OF ALBERTA +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MYPI2026004802
Authority / Receiving Office
MY · MY
Patent Type
Applications
Current Assignee / Owner
Priority Date
2020-11-16
Filing Date
2021-02-26
Publication Date
2021-08-26
Patent Text Reader

Abstract

The invention relates in various aspects to a recombinant poxvirus comprising a nucleic acid encoding a SARS-CoV-2 virus protein, methods for producing such viruses and the use of such viruses. The recombinant poxviruses are well suited, among others, as protective virus vaccines against SARS-CoV-2 virus. FIGURE 4
Need to check novelty before this filing date? Find Prior Art